AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.530
-0.029 (-5.17%)
At close: Nov 22, 2024, 4:00 PM
0.532
+0.002 (0.36%)
After-hours: Nov 22, 2024, 7:50 PM EST
AEON Biopharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
10
Market Cap
20.95M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bionano Genomics | 33.33M |
NeuroOne Medical Technologies | 3.92M |
BioXcel Therapeutics | 2.28M |
Cyclo Therapeutics | 870.73K |
GlycoMimetics | 10.00K |
AEON News
- 9 days ago - AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024 - GlobeNewsWire
- 3 months ago - AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan - GlobeNewsWire
- 6 months ago - AEON Biopharma Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 7 months ago - AEON Biopharma Provides Update on Development Pipeline - GlobeNewsWire
- 7 months ago - AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine - GlobeNewsWire
- 8 months ago - CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants - GlobeNewsWire